Department of NanoEngineering, Chemical Engineering Program, Moores Cancer Center, University of California San Diego, La Jolla, San Diego, CA, 92093, USA.
Adv Healthc Mater. 2022 Apr;11(7):e2101349. doi: 10.1002/adhm.202101349. Epub 2021 Aug 31.
White blood cells (WBCs) are immune cells that play essential roles in critical diseases including cancers, infections, and inflammatory disorders. Their dynamic and diverse functions have inspired the development of WBC membrane-coated nanoparticles (denoted "WBC-NPs"), which are formed by fusing the plasma membranes of WBCs, such as macrophages, neutrophils, T cells, and natural killer cells, onto synthetic nanoparticle cores. Inheriting the entire source cell antigens, WBC-NPs act as source cell decoys and simulate their broad biointerfacing properties with intriguing therapeutic potentials. Herein, the recent development and medical applications of WBC-NPs focusing on four areas, including WBC-NPs as carriers for drug delivery, as countermeasures for biological neutralization, as nanovaccines for immune modulation, and as tools for the isolation of circulating tumor cells and fundamental research is reviewed. Overall, the recent development and studies of WBC-NPs have established the platform as versatile nanotherapeutics and tools with broad medical application potentials.
白细胞(WBCs)是免疫细胞,在癌症、感染和炎症性疾病等重大疾病中发挥着重要作用。它们的动态和多样化功能激发了 WBC 膜包覆纳米颗粒(表示为“WBC-NPs”)的发展,这些颗粒是通过将 WBC 的质膜,如巨噬细胞、中性粒细胞、T 细胞和自然杀伤细胞,融合到合成纳米颗粒核心上而形成的。WBC-NPs 继承了整个源细胞的抗原,充当源细胞诱饵,并模拟其广泛的生物界面特性,具有令人着迷的治疗潜力。本文重点综述了 WBC-NPs 在四个领域的最新发展和医学应用,包括 WBC-NPs 作为药物传递载体、作为生物中和对策、作为免疫调节的纳米疫苗,以及作为循环肿瘤细胞分离和基础研究工具。总的来说,WBC-NPs 的最新发展和研究已经确立了该平台作为多功能纳米治疗剂和工具的地位,具有广泛的医学应用潜力。